Voon Ong

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Kidney Transplantation

Chronic Lymphocytic Leukemia

Candida Albicans

Top Venues

Pharmacotherapy

Antimicrobial agents and chemotherapy

Microbiology spectrum

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Shawn Flanagan, Voon Ong, Thomas C Marbury, Alena Jandourek, Ronak G Gandhi, Taylor Sandison
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects. Pharmacotherapy (2024)
Shawn Flanagan, Voon Ong, Thomas C Marbury, Alena Jandourek, Ronak G Gandhi, Taylor Sandison
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects. Pharmacotherapy 44 (6) (2024)
Shawn Flanagan, Voon Ong, Thomas C Marbury, Alena Jandourek, Ronak G Gandhi, Taylor Sandison
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects. Pharmacotherapy 44 (6) (2024)
Shawn Flanagan, Helen Walker, Voon Ong, Taylor Sandison
Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations. Microbiology spectrum (2023)
Voon Ong, Sarah Wills, Deborah Watson, Taylor Sandison, Shawn Flanagan
Metabolism, Excretion, and Mass Balance of [14C]-Rezafungin in Animals and Humans. Antimicrobial agents and chemotherapy (2021)
Lynn Miesel, Melanie T Cushion, Alan Ashbaugh, Santiago R Lopez, Voon Ong
Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia. Antimicrobial agents and chemotherapy 65 (3) (2021)
Lynn Miesel, Kun-Yuan Lin, Voon Ong
Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy. Pharmacology research & perspectives 7 (6) (2019)